Literature DB >> 31302378

Minimally invasive approach to non-missile penetrating spinal injury with resultant retained foreign body: A case report and review of the literature.

Krisztina Moldovan1, Albert E Telfeian2, Jared S Fridley3, Ziya L Gokaslan4, Daniel Aghion5, Adetokunbo A Oyelese6.   

Abstract

Non- missile penetrating spinal injury (NMPSI) is a rare entity in North America and as a result there is no clear treatment paradigm. According to the literature, NMPSI causes serious acute neurological deficits and can also lead to devastating delayed complications in cases of untreated retained foreign bodies (RFB). In this report we present an acute case of NMPSI to the thoracic spine resulting in RFB treated by operative removal using minimally invasive fluoroscopic technique. While in prior published cases of NMPSI operative intervention was accomplished through laminectomy, our case presents an alternative, less invasive approach which may results in shorter recovery time. We also review the literature on NMPSI, including reports on both acute cases and chronic presentation due to RFBs. Based on this review, we conclude that NMPSI associated with RFB should be managed with operative intervention.
Copyright © 2019. Published by Elsevier B.V.

Entities:  

Keywords:  Minimally invasive spine surgery; Non-missile penetrating spine injury; Retained foreign body; Spinal cord injury; Spinal stab wound

Year:  2019        PMID: 31302378     DOI: 10.1016/j.clineuro.2019.105405

Source DB:  PubMed          Journal:  Clin Neurol Neurosurg        ISSN: 0303-8467            Impact factor:   1.876


  2 in total

Review 1.  Nonmissile penetrating spinal injuries: Mechanisms, expectations, and management.

Authors:  Brian Fiani; Ryan Arthur Figueras; Frank De Stefano; Neha Gautam; Asif Khan; Marisol Soula
Journal:  Surg Neurol Int       Date:  2020-11-25

2.  Laminectomy for Penetrating Spinal Cord Injury with Retained Foreign Bodies.

Authors:  Peng Zhang; Xiaoyang Liu; Dongsheng Zhou; Qingyu Zhang
Journal:  Orthop Surg       Date:  2022-06-09       Impact factor: 2.279

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.